Recognizing Optimal Care Strategies in the
Treatment of Major Depressive Disorder

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session from the 2018 Fall Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2019 to January 1, 2020

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Takeda Pharmaceuticals USA and Lundbeck

Major depression is a debilitating condition that affects more than 350 million people worldwide. With appropriate treatment, about 75% of individuals with major depressive disorder (MDD) can achieve a significant reduction in symptoms, although as many as 50% of patients may not respond to the initial treatment trial. These numbers are staggering and many of these patients report cognitive difficulties and comorbidities to include alcohol or substance abuse, type 2 diabetes, isolation, work and personal conflicts, and an increased chance of suicide. Measurement-based assessment tools can help screen for and quantify the degree of depression; however, these tools continue to be underutilized in everyday practice. It is important to assess the overall severity of depressive symptoms as symptom severity correlates with suicide risk. Treatment methods for depression are often multi-faceted which may include combining medication with psychotherapy. Pharmacologic antidepressant treatments range from selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), atypical and tricyclic antidepressants, and monoamine oxidase inhibitors. Electroconvulsive treatment (ECT), psychotherapy, and other somatic options are also available. It’s critical to personalize a treatment plan for each patient as the ultimate goal of care providers is to move patients suffering from MDD to remission, then recovery, and to avoid a relapse

Upon completion of this activity, participants will be able to:

  • Evaluate the efficacy and safety of pharmacologic therapies for major depressive disorder

  • Assess the proper diagnosis and screening tools for major depressive disorder including cognitive and residual symptoms

  • Discuss optimal care strategies to maintain patient adherence with pharmacologic therapy for major depressive disorder

  • Review evidence-based collaborative care models in major depressive disorder

Faculty: Bradley N. Gaynes, MD, MPH
Professor of Psychiatry
Associate Chair of Research Training and Education
Department of Psychiatry
University of North Carolina School of Medicine


Dr. Gaynes serves on an advisory board for LivaNova/Cyberonics. He serves as a consultant for Janssen Pharmaceuticals. He has received grant/research support from the Agency for Healthcare Research and Quality and the National Institute of Mental Health. His presentation has been reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Takeda Pharmaceuticals USA and Lundbeck

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue